JOHNSON & JOHNSON Long-Term Concentrated

Location: New Brunswick, NJ

CIK: 0000200406 · Show all filings

Period: Q2 2026 (← Previous)

Filing Date: Aug 6, 2026

Total Value: $799M (100.0% shares, 0.0% debt)

Holdings (15)

New Positions (1)

CBRS CEREBRAS SYSTEMS INC 1.5%

Value $11.84M Shares 53,586 Est. Cost $221.00 Unrealized —

Ticker	Issuer	Shares	Value	%	Est. Cost	Unrealized	Class	CUSIP
CBRS	CEREBRAS SYSTEMS INC	53,586	$11.84M	1.5%	$221.00	—	COM CL A	15675D103

Exited Positions (2)

RLYB Rallybio Corporation 0.2%

Value $1.372M Shares 152,901 Est. Cost $5.22 Unrealized —

NNOX Nano-X Imaging Ltd. 0.0%

Value $190K Shares 83,554 Est. Cost $15.61 Unrealized —

Ticker	Issuer	Shares	Value	%	Est. Cost	Unrealized	Class	CUSIP
RLYB	Rallybio Corporation	152,901	$1.372M	0.2%	$5.22	—	—	75120L209
NNOX	Nano-X Imaging Ltd.	83,554	$190K	0.0%	$15.61	—	—	M70700105

Unchanged Positions (14)

PTGX PROTAGONIST THERAPEUTICS INC 37.6%

Value $300M Shares 2,449,183 Est. Cost $42.63 Unrealized —

NBTX NANOBIOTIX 26.5%

Value $212M Shares 5,623,816 Est. Cost $7.53 Unrealized —

MGTX MEIRAGTX HLDGS PLC 11.2%

Value $89.72M Shares 6,641,064 Est. Cost $9.84 Unrealized —

RAPP RAPPORT THERAPEUTICS INC 9.3%

Value $74.36M Shares 1,784,517 Est. Cost $23.15 Unrealized —

CVRX CVRX INC 2.6%

Value $20.69M Shares 4,024,861 Est. Cost $19.85 Unrealized —

LEGN LEGEND BIOTECH CORP 2.9%

Value $23.53M Shares 814,586 Est. Cost $50.56 Unrealized —

CTNM CONTINEUM THERAPEUTICS INC 4.1%

Value $32.44M Shares 1,979,173 Est. Cost $16.10 Unrealized —

FATE FATE THERAPEUTICS INC 1.1%

Value $9.123M Shares 3,379,064 Est. Cost $78.44 Unrealized —

XNCR XENCOR INC 1.5%

Value $12.04M Shares 748,062 Est. Cost $37.91 Unrealized —

PRCT PROCEPT BIOROBOTICS CORP 1.0%

Value $8.082M Shares 357,939 Est. Cost $38.38 Unrealized —

NMRA NEUMORA THERAPEUTICS INC. 0.4%

Value $3.144M Shares 1,849,445 Est. Cost $12.57 Unrealized —

ACET ADICET BIO INC 0.0%

Value $197K Shares 22,779 Est. Cost $11.05 Unrealized —

VOR VOR BIOPHARMA INC 0.1%

Value $989K Shares 53,732 Est. Cost $18.62 Unrealized —

LAB STANDARD BIOTOOLS INC 0.0%

Value $257K Shares 311,967 Est. Cost $2.41 Unrealized —

Ticker	Issuer	Shares	Value	%	Est. Cost	Unrealized	Class	CUSIP
PTGX	PROTAGONIST THERAPEUTICS INC	2,449,183	$300M	37.6%	$42.63	—	COM	74366E102
NBTX	NANOBIOTIX	5,623,816	$212M	26.5%	$7.53	—	SPONSORED ADS	63009J107
MGTX	MEIRAGTX HLDGS PLC	6,641,064	$89.72M	11.2%	$9.84	—	COM	G59665102
RAPP	RAPPORT THERAPEUTICS INC	1,784,517	$74.36M	9.3%	$23.15	—	COM	75383L102
CVRX	CVRX INC	4,024,861	$20.69M	2.6%	$19.85	—	COM	126638105
LEGN	LEGEND BIOTECH CORP	814,586	$23.53M	2.9%	$50.56	—	SPONSORED ADS	52490G102
CTNM	CONTINEUM THERAPEUTICS INC	1,979,173	$32.44M	4.1%	$16.10	—	CL A	21217B100
FATE	FATE THERAPEUTICS INC	3,379,064	$9.123M	1.1%	$78.44	—	COM	31189P102
XNCR	XENCOR INC	748,062	$12.04M	1.5%	$37.91	—	COM	98401F105
PRCT	PROCEPT BIOROBOTICS CORP	357,939	$8.082M	1.0%	$38.38	—	COM	74276L105
NMRA	NEUMORA THERAPEUTICS INC.	1,849,445	$3.144M	0.4%	$12.57	—	COM	640979100
ACET	ADICET BIO INC	22,779	$197K	0.0%	$11.05	—	COM NEW	007002207
VOR	VOR BIOPHARMA INC	53,732	$989K	0.1%	$18.62	—	COM NEW	929033207
LAB	STANDARD BIOTOOLS INC	311,967	$257K	0.0%	$2.41	—	COM	34385P108